Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL797847 | 0.84 | KDM4E (0.47) | KDM4EALDH1A1HPGDGAARAB9A | |
| SCHEMBL6364814 | 0.80 | KDM4E (0.44) | KDM4EALDH1A1HPGDGAARAB9A | |
| SCHEMBL27596054 | 0.76 | KDM4E (0.43) | KDM4EALDH1A1HPGDGAARAB9A | |
| SCHEMBL797816 | 0.75 | KDM4E (0.42) | KDM4EALDH1A1HPGDGAARAB9A | |
| SCHEMBL797874 | 0.71 | LDHA (0.44) | KDM4EALDH1A1HPGDGAACYP1A2 | |
| SCHEMBL796328 | 0.71 | KDM4E (0.40) | KDM4EALDH1A1HPGDNCEH1MEN1 | |
| SCHEMBL28059845 | 0.70 | KDM4E (0.41) | KDM4EALDH1A1HPGDGAARAB9A | |
| SCHEMBL797469 | 0.70 | KDM4E (0.67) | KDM4EALDH1A1HPGDGAARAB9A | |
| SCHEMBL797601 | 0.69 | LDHA (0.36) | KDM4EALDH1A1HPGDGAA | |
| SCHEMBL7915227 | 0.68 | KDM4E (0.58) | KDM4EALDH1A1HPGDGAARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050240061-A1 | Functional thin film | JAPAN SCIENCE AND TECHNOLOGY AGENCY | 2005-10-27 | — | — | US | disclosed |
| EP-1493796-A1 | FUNCTIONAL THIN FILM | Japan Science and Technology Agency (JP) | 2005-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050240061-A1 | Functional thin film | H1-10, H1-0, H1-2 | KDM4E 2385/4885ALDH1A1 1285/4885HPGD 4240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.